2023 annual financial data
ResMed 2023 Net margin
Direct answer
Net margin was 21.25%.
Operating income was 1,131,871,000 USD and net income was 897,556,000 USD.
Operating cash flow was 693,299,000 USD.
Get free ResMed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,222,993,000 USD
- Operating income
- 1,131,871,000 USD
- Net income
- 897,556,000 USD
- Operating cash flow
- 693,299,000 USD